Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
API5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TNPO1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SNCA - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ANKS1A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NOTCH2NL - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC101060399 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PRPF19 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DCAF10 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SNORD19B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DUSP6 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SRP72 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ITPR1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
WWTR1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MACF1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HNRNPU - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
C1orf216 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MID1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ITGB5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GULP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GLS - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on